<?xml version="1.0" encoding="UTF-8"?>
<p>Given the occurrence of cell culture-selected mutations [
 <xref rid="B193-pharmaceuticals-12-00147" ref-type="bibr">193</xref>], using yeast as the alternative for determining the drug susceptibility of viruses may prove useful given that the proteins can be expressed intact with less likelihood of mutations. Given the benefits of yeast biotechnology, yeast can be used to identify and produce anti-influenza antibodies for vaccines and therapy [
 <xref rid="B194-pharmaceuticals-12-00147" ref-type="bibr">194</xref>]. Since yeasts have already been used to generate novel influenza vaccines [
 <xref rid="B195-pharmaceuticals-12-00147" ref-type="bibr">195</xref>,
 <xref rid="B196-pharmaceuticals-12-00147" ref-type="bibr">196</xref>], there seems to be untapped potential in using yeast to better elucidate the mysteries of influenza. 
</p>
